Trial intelligence / Profile preview

Paracetamol pharmacokinetics before and after Roux-en-Y gastric bypass

NL-OMON25518Not yet recruiting

Sponsor
N/A
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of acetaminophen in class III obesity (2 arms), sponsored by N/A. Primary endpoint: Pharmacokinetics of paracetamol. Planned start Feb 2020; status: not yet recruiting.

02

Drugs

acetaminophen
03

Conditions

class III obesity

Beyond the preview

Go deeper on NL-OMON25518.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON25518.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call